Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Electroconvulsive Therapy01:30

Electroconvulsive Therapy

Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early years,...
Psychosurgery01:30

Psychosurgery

Psychosurgery, the surgical alteration or permanent removal of brain tissue to alleviate severe psychological conditions, stands as one of the most radical and controversial treatments in the history of mental health care. Its development and application have evolved significantly, marked by dramatic shifts in scientific understanding and ethical perspectives.
Historical Development of Psychosurgery
In the 1930s, Portuguese neurologist Antonio Egas Moniz introduced a surgical procedure designed...
Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Duration of clinically meaningful improvement in pain as a patient-centered endpoint in acute pain trials.

Pain·2026
Same author

Association of perioperative gabapentinoids with persistent opioid requirements following below knee amputation - A nationwide claims-based retrospective cohort study.

Journal of clinical anesthesia·2026
Same author

Association of preoperative corticosteroids with persistent opioid requirements following total knee arthroplasty: an exploratory population-based cohort study.

Canadian journal of anaesthesia = Journal canadien d'anesthesie·2026
Same author

Towards a tool to discriminate between pain mechanistic descriptors: expert ranking of clinical features and allocation of weights using a forced choice paradigm.

Pain·2026
Same author

Med Spas: Patient Safety and Accreditation.

Aesthetic surgery journal·2026
Same author

ZW191, an FRα-Targeted Topoisomerase 1 Inhibitor ADC with a Differentiated Antitumor Efficacy and Tolerability Profile.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same journal

Successful Use of Electroconvulsive Therapy in Treatment-Resistant Catatonia With Comorbid Parkinson Disease and Neuroborreliosis: A Case Report.

The journal of ECT·2026
Same journal

Electroconvulsive Therapy in Movement Disorders: A Systematic Review.

The journal of ECT·2026
Same journal

Presyncope During Repetitive Transcranial Magnetic Stimulation With Treatment Continuation.

The journal of ECT·2026
Same journal

Comparison of Electroconvulsive Therapy Seizure Outcomes When Using Methohexital Versus Propofol: A Brief Retrospective Report.

The journal of ECT·2026
Same journal

Changes in the Use of Repetitive Transcranial Magnetic Stimulation Therapy Between 2016 and 2022 in Northern Finland.

The journal of ECT·2026
Same journal

Evaluation of Cardiac Adverse Effects After Transition From Bitemporal to Bifrontal ECT.

The journal of ECT·2026
See all related articles

Related Experiment Video

Updated: May 28, 2026

Pupillary Response as Assessment of Effective Seizure Induction by Electroconvulsive Therapy
04:51

Pupillary Response as Assessment of Effective Seizure Induction by Electroconvulsive Therapy

Published on: April 11, 2019

Access to electroconvulsive therapy services in Canada.

Nicholas John Delva1, Peter Graf, Simon Patry

  • 1Department of Psychiatry, Dalhousie University, Halifax, Canada. delvan@cdha.nshealth.ca

The Journal of ECT
|October 11, 2011
PubMed
Summary
This summary is machine-generated.

Electroconvulsive therapy (ECT) is geographically accessible for most Canadians. However, significant barriers like staffing shortages and funding limit access even when centers are nearby.

More Related Videos

Combined Transcranial Magnetic Stimulation and Electroencephalography of the Dorsolateral Prefrontal Cortex
07:42

Combined Transcranial Magnetic Stimulation and Electroencephalography of the Dorsolateral Prefrontal Cortex

Published on: August 17, 2018

Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins
09:07

Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins

Published on: August 15, 2017

Related Experiment Videos

Last Updated: May 28, 2026

Pupillary Response as Assessment of Effective Seizure Induction by Electroconvulsive Therapy
04:51

Pupillary Response as Assessment of Effective Seizure Induction by Electroconvulsive Therapy

Published on: April 11, 2019

Combined Transcranial Magnetic Stimulation and Electroencephalography of the Dorsolateral Prefrontal Cortex
07:42

Combined Transcranial Magnetic Stimulation and Electroencephalography of the Dorsolateral Prefrontal Cortex

Published on: August 17, 2018

Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins
09:07

Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins

Published on: August 15, 2017

Area of Science:

  • Neuroscience
  • Psychiatry
  • Health Services Research

Background:

  • Electroconvulsive therapy (ECT) is a vital treatment for severe mental health conditions.
  • Understanding access to ECT is crucial for equitable healthcare delivery in Canada.

Purpose of the Study:

  • To determine the factors influencing access to electroconvulsive therapy (ECT) across Canada.
  • To identify both geographic and non-geographic barriers to ECT provision.

Main Methods:

  • Surveyed 175 Canadian healthcare centers providing ECT.
  • Utilized geographic information systems and population data to assess travel times.
  • Analyzed questionnaire responses to identify local access barriers.

Main Results:

  • 84% of Canadians live within a 1-hour drive of an ECT center; 5% live over 5 hours away.
  • Significant provincial disparities exist; no ECT services are available in Canadian territories.
  • Non-geographic barriers include lack of anesthesiologists (59%), logistical issues (52%), and funding (14%).

Conclusions:

  • ECT is geographically accessible for the majority of Canadians.
  • Inadequate staffing, treatment space, and funding present significant non-geographic barriers.
  • Addressing these systemic issues is essential to improve overall ECT access.